Detection and quantification of mutations in the plasma of patients with colorectal tumors
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The early detection of cancers through analysis of circulating DNA could have a substantial impact on morbidity and mortality. To achieve this goal, it is essential to determine the number of mutant molecules present in the circulation of cancer patients and to develop methods that are sufficiently sensitive to detect these mutations. Using a modified version of a recently developed assay for this purpose, we found that patients with advanced colorectal cancers consistently contained mutant adenomatous polyposis coli ( APC ) DNA molecules in their plasma. The median number of APC DNA fragments in such patients was 47,800 per ml of plasma, of which 8% were mutant. Mutant APC molecules were also detected in >60% of patients with early, presumably curable colorectal cancers, at levels ranging from 0.01% to 1.7% of the total APC molecules. These results have implications for the mechanisms through which tumor DNA is released into the circulation and for diagnostic tests based on this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is a crucial consideration when considering cfDNA as a template as its concentration can range considerably; from 2 to 30 ng/ml plasma in healthy individuals to 180–600 ng/ml plasma both during pregnancy and in cancer patients (13,16,18,22–24).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationJahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1977) · PubMed · Cited by 1,801
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Self-citationDressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844
Self-citation
Research works printed but not linked: 4
- 10.1002/(SICI)1096-9896(200001)190:1<6::AID-PATH486>3.0.CO;2-M · doi:10.1002/(sici)1096-9896(200001)190:1<6::aid-path486>3.0.co;2-m
- Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. (1977) Cancer Res. 37, 646-650.837366
- Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M. A. & Tavecchio, L. (2001) Cancer Res. 61, 4675-4678.11406535
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D. & Knippers, R. (2001) Cancer Res. 61, 1659-1665.11245480
Cited by
Items 501–600 of 1,000
New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer
Cui, J.-Z., Chew, Z. H., & Lim, L. H. K. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107079 · Cited by 37
Stadler, J. T., Eder, J., Pratscher, B., Brandt, S., Schneller, D., Müllegger, R., Vogl, C., Trautinger, F., Brem, G., & Burgstaller, J. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142273 · Cited by 37
Junca, A., Tachon, G., Evrard, C., Villalva, C., Frouin, É., Karayan, L., & Tougeron, D. (2020) · Cancers · doi:10.3390/cancers12061482 · Cited by 41
cfDNA detection for HPV+ squamous cell carcinomas
Chatfield‐Reed, K., Roche, V., & Pan, Q. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104958 · Cited by 38
Molnar, B. A., Galamb, O., Kalmár, A., Barták, B. K., Nagy, Z. B., Tóth, K., Tulassay, Z., Igaz, P., & Dank, M. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1613891 · Cited by 37
Strategies for Validation and Testing of DNA Methylation Biomarkers
Noehammer, C., Pulverer, W., Hassler, M. R., Hofner, M., Wielscher, M., Vierlinger, K., Liloglou, T., McCarthy, D., Jensen, T. J., Nygren, A. O. H., et al. (2014) · Epigenomics · doi:10.2217/epi.14.43 · Cited by 37
Next-Generation Stool DNA Testing: Expanding the Scope
Ahlquist, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.025 · Cited by 39
Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats
García-Olmo, D. C., Picazo, M. G., Toboso, I., Asensio, A. I., & García‐Olmo, D. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-8 · Cited by 39
Jiang, T., Zhai, C., Su, C., Ren, S., & Zhou, C. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.06.013 · Cited by 36
Vandeputte, C., Kehagias, P., Housni, H. E., Ameye, L., Laes, J., Desmedt, C., Sotiriou, C. P., Deleporte, A., Puleo, F., Geboes, K., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24879 · Cited by 39
Sim, W. C., Loh, C. H., Toh, G. L.-X., Lim, C. W., Chopra, A., Chang, A. Y. C., & Goh, L. L. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.08.007 · Cited by 38
Circulating cell-free tumor DNA analysis in pediatric cancers
Andersson, D., Fagman, H., Dalin, M. G., & Ståhlberg, A. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.003 · Cited by 34
Yu, Y., Wu, T., Johnson-Buck, A. E., Li, L., & Su, X. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.03.070 · Cited by 34
Detecting circulating tumor DNA in renal cancer: An open challenge
Corrò, C., Hejhal, T., Poyet, C., Sulser, T., Hermanns, T., Winder, T. L., Prager, G. W., Wild, P. J., Frew, I. J., Moch, H., et al. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.02.009 · Cited by 33
Young, G. P., Symonds, E. L., Nielsen, H. J., Ferm, L., Christensen, I. J., Dekker, E., Vlugt, M. V., Mallant–Hent, R. C., Boulter, N. R., Yu, B., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-020-00999-y · Cited by 33
The potential of DNA modifications as biomarkers and therapeutic targets in oncology
Jankowska, A. M., Millward, C. L., & Caldwell, C. W. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1084229 · Cited by 35
Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma
Perego, R., Corizzato, M., Brambilla, P., Ferrero, S., Bianchi, C., Fasoli, E., Signorini, S. G., Torsello, B., Invernizzi, L., Bombelli, S., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.03.008 · Cited by 35
García-Olmo, D. C., Samos, J., Picazo, M. G., Asensio, A. I., Toboso, I., & García‐Olmo, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.07.003 · Cited by 37
Rao, S., Han, A., Zukowski, A., Kopin, E. G., Sartorius, C. A., Kabos, P., & Ramachandran, S. (2022) · Science Advances · doi:10.1126/sciadv.abm4358 · Cited by 41
Yu, S., Cao, S., He, S., & Zhang, K. (2023) · Small Methods · doi:10.1002/smtd.202201624 · Cited by 32
Kajiwara, T., Matsushita, K., Itoga, S., Tamura, M., Tanaka, N., Tomonaga, T., Matsubara, H., Shimada, H., Habara, Y., Matsuo, M., et al. (2012) · Cancer Science · doi:10.1111/cas.12058 · Cited by 40
Comparison of Target Enrichment Platforms for Circulating Tumor DNA Detection
Lam, S. N., Zhou, Y., Chan, Y. M., Foo, C. M., Lee, P. Y., Mok, W. Y., Wong, W. S., Fung, Y. Y., Wong, K. Y., Huang, J. Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60375-x · Cited by 34
ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)
Masfarré, L., Vidal, J., Fernández‐Rodríguez, C., & Montagut, C. O. (2021) · Cancers · doi:10.3390/cancers13122869 · Cited by 37
DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies
Gonçalves, E., Gonçalves-Reis, M., Pereira‐Leal, J. B., & Cardoso, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-15058-0 · Cited by 35
Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer
Yokoi, K., Yamashita, K., & Watanabe, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040735 · Cited by 37
Cell‐free DNA — Minimally invasive marker of hematological malignancies
Kubaczková, V., Vrábel, D., Sedlaříková, L., Bešše, L., & Ševčíková, S. (2017) · European Journal Of Haematology · doi:10.1111/ejh.12925 · Cited by 32
Microfluidic Technologies for cfDNA Isolation and Analysis
Xu, Z., Qiao, Y., & Tu, J. (2019) · Micromachines · doi:10.3390/mi10100672 · Cited by 31
Colorectal carcinoma screening: Established methods and emerging technology
Hissong, E. M., & Pittman, M. E. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1670614 · Cited by 38
dPCR application in liquid biopsies: divide and conquer
Moreno‐Manuel, A., Fariñas, S. C., Obrador‐Hevia, A., Blasco, A., Fernandez-Diaz, A. B., Sirera, R., Camps, C., & Lewintre, E. J. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1860759 · Cited by 34
Liquid-based biomarkers in breast cancer: looking beyond the blood
Shuai, Y., Ma, Z., Ju, J., Wei, T., Gao, S., Kang, Y., Yang, Z., Wang, X., Yue, J., & Yuan, P. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04660-z · Cited by 34
Deftereos, G., Finkelstein, S. D., Jackson, S. A., Ellsworth, E., Krishnamurti, U., Liu, Y., Silverman, J. F., Binkert, C. R., Ujevich, B. A., & Mohanty, A. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.147 · Cited by 30
Evaluation of Exome Sequencing to Estimate Tumor Burden in Plasma
Klevebring, D., Neiman, M., Sundling, S., Eriksson, L., Darai‐Ramqvist, E., Celebioglu, F., Czene, K., Hall, P., Egevad, L., Grönberg, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104417 · Cited by 29
Technical progress in circulating tumor DNA analysis using next generation sequencing
Bai, Y., Wang, Z., Liu, Z., Liang, G., Gu, W., & Ge, Q. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.101480 · Cited by 30
Zvereva, M. I., Roberti, G., Durand, G., Voegele, C., Nguyen, M. D., Delhomme, T. M., Chopard, P., Fabiánová, E., Adamčáková, Z. K., Holcátová, I., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.042 · Cited by 31
Emaus, M. N., & Anderson, J. L. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.04.078 · Cited by 31
Recognition of Single‐Point Mutation Using a Biological Nanopore
Liu, P., & Kawano, R. (2020) · Small Methods · doi:10.1002/smtd.202000101 · Cited by 30
Häfner, N., Diebolder, H., Jansen, L., Hoppe, I., Dürst, M., & Runnebaum, I. B. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.11.018 · Cited by 30
Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients
Eide, N. A., Faye, R. S., Høifødt, H. K., Øvergaard, R., Jebsen, P., Kvalheim, G., & Fodstad, Ø. (2008) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2008.01378.x · Cited by 30
Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?
Stetson, D., Labrousse, P., Russell, H., Shera, D. M., Abbosh, C., Dougherty, B. A., Barrett, J. C., Hodgson, D., & Hadfield, J. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02301 · Cited by 36
Principles of digital sequencing using unique molecular identifiers
Andersson, D., Kebede, F. T., Escobar, M., Österlund, T., & Ståhlberg, A. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101253 · Cited by 32
Tu, M. K., Chia, D., Wei, F., & Wong, D. T. (2016) · The Analyst · doi:10.1039/c5an01863c · Cited by 32
Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers
Swiecicki, P. L., Brennan, J. R., Mierzwa, M. L., Spector, M. E., & Brenner, J. C. (2018) · The Laryngoscope · doi:10.1002/lary.27725 · Cited by 33
Diagnostic and prognostic biomarkers in pancreatic carcinoma.
Liang, J. J., Kimchi, E. T., Staveley-O’Carroll, K. F., & Tan, D. (2009) · PubMed · Cited by 32
Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis
Zheng, Y., Chen, L., Li, J., Yu, B., Su, L., Chen, X., Yu, Y., Yan, M., Liu, B., & Zhu, Z. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.09.006 · Cited by 29
Quantification of plasma DNA as a prognostic indicator in canine lymphoid neoplasia
Schaefer, D. M. W., Forman, M. A., Kisseberth, W. C., Lehman, A. M., Kelbick, N. T., Harper, P., & Rush, L. J. (2007) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2007.00122.x · Cited by 29
Wu, J., Tang, W., Huang, L.-Q., Hou, N., Wu, J., Cheng, X., Ma, D., Qian, P., Shen, Q., Guo, W., et al. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.10.002 · Cited by 32
Pre-analytical issues in liquid biopsy – where do we stand?
Fleischhacker, M., & Schmidt, B. (2020) · Journal of Laboratory Medicine · doi:10.1515/labmed-2019-0167 · Cited by 32
Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection
Mansour, H. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00182 · Cited by 30
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
Ross, K., Pailler, E., Faugeroux, V., Taylor, M., Oulhen, M., Auger, N., Planchard, D., Soria, J., Lindsay, C. R., Besse, B., et al. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1111139 · Cited by 31
Liquid biopsy: creating opportunities in brain space
Trivedi, R., & Bhat, K. P. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02446-0 · Cited by 27
Advances in Circulating Tumor DNA Analysis
Perakis, S. O., Auer, M., Belic, J., & Heitzer, E. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.11.005 · Cited by 40
Cell-free DNA as a post-treatment surveillance strategy: current status
Burgener, J., Rostami, A., Carvalho, D. D. D., & Bratman, S. V. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.01.009 · Cited by 27
Lapitan, L. D., Xu, Y., Guo, Y., & Zhou, D. (2018) · Nanoscale · doi:10.1039/c8nr07641c · Cited by 27
Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine
Kerachian, M. A., Poudineh, A., & Thiery, J. P. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102827 · Cited by 27
Ge, Z., Helmijr, J., Jansen, M. P. H. M., Boor, P. P. C., Noordam, L., Peppelenbosch, M. P., Kwekkeboom, J., Kraan, J., & Sprengers, D. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101073 · Cited by 28
Shukla, D., Kale, A. D., Hallikerimath, S. R., Yerramalla, V., & Subbiah, V. (2012) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2012.04.039 · Cited by 27
Predictive response biomarkers in rectal cancer neoadjuvant treatment
Agostini, M., Crotti, S., Bedin, C., Cecchin, E., Maretto, I., D’Angelo, E., Pucciarelli, S., & Nitti, D. (2014) · Frontiers in Bioscience-Scholar · doi:10.2741/s418 · Cited by 27
Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma
Wu, F., Luo, L., Xu, W., & Li, J. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3529-9 · Cited by 27
Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications
Park, J., Lee, Y., Agopian, V. G., Liu, J. S., Koltsova, E. K., You, S., Zhu, Y., Tseng, H., & Yang, J. D. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0541 · Cited by 35
Analytical techniques for nucleic acid and protein detection with single-molecule sensitivity
Shin, S., Kim, J., Song, E., Han, S. H., & Hohng, S. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01453-w · Cited by 40
Feasibility of Cell-Free Circulating Tumor DNA Testing for Lung Cancer
Santarpía, M., Karachaliou, N., González‐Cao, M., Altavilla, G., Giovannetti, E., & Rosell, R. (2016) · Biomarkers in Medicine · doi:10.2217/bmm.16.6 · Cited by 27
Ladas, I., Fitarelli-Kiehl, M., Song, C., Adalsteinsson, V. A., Parsons, H. A., Lin, N., Wagle, N., & Makrigiorgos, G. M. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.272849 · Cited by 26
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
Bignucolo, A., Mattia, E. D., Cecchin, E., Roncato, R., & Toffoli, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071522 · Cited by 29
Technologies for analysis of circulating tumour DNA: Progress and promise
Zou, Z., Qi, P., Qing, Z., Zheng, J., Yang, S., Chen, W., & Yang, R. (2017) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2017.08.004 · Cited by 26
Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review
Chen, X., Wang, L., & Lou, J. (2020) · Medical Science Monitor · doi:10.12659/msm.921040 · Cited by 39
The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
Lu, Y., & Li, L. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211043784 · Cited by 27
Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays
Chen, L., Eriksson, A., Weström, S., Pandzic, T., Lehmann, S., Cavelier, L. B., & Landegren, U. D. (2022) · Nature Communications · doi:10.1038/s41467-022-31397-y · Cited by 33
A hitchhiker’s guide to cell-free DNA biology
Mouliere, F. C. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac066 · Cited by 32
Cheng, S. H., Lau, K., Li, C. K., Chan, N. P. H., Ip, R. K. L., Cheng, C. K., Lee, V., Shing, M. M. K., Leung, A. W. K., Ha, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069467 · Cited by 28
Utilizing circulating tumour DNA in radiation oncology
Rostami, A., & Bratman, S. V. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.004 · Cited by 26
Xu, J., Li, L., Chen, N., She, Y., Wang, S., Liu, N., & Xiao, X. (2017) · Chemical Communications · doi:10.1039/c7cc04816e · Cited by 26
Galot, R., & Machiels, J. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.101992 · Cited by 31
Hansen, R. R., Avens, H. J., Shenoy, R., & Bowman, C. N. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2259-6 · Cited by 26
Selecting short DNA fragments in plasma improves detection of circulating tumour DNAPreprint
Mouliere, F. C., Piskorz, A., Chandrananda, D., Moore, E. K., Morris, J., Smith, C. G., Goranova, T., Heider, K., Mair, R. J., Supernat, A. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/134437 · Cited by 28
Zhou, Y., Wang, C., Zhu, H., Lin, Y., Pan, B., Zhang, X., Huang, X., Xu, Q., Xu, Y., & Sun, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158143 · Cited by 26
Clinical utility of circulating cell-free DNA in advanced colorectal cancer
Pereira, A. A. L., Morelli, M. P., Overman, M. J., Kee, B. K., Fogelman, D. R., Vilar, E., Shureiqi, I., Raghav, K. P. S., Eng, C., Manuel, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183949 · Cited by 26
Emaus, M. N., Varona, M., & Anderson, J. L. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.04.005 · Cited by 27
Enrichment and Analysis of ctDNA
Gilson, P. (2019) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-26439-0_10 · Cited by 26
Yang, X., Cai, G., Han, B.-W., Guo, Z.-W., Wu, Y.-S., Lyu, X., Huang, L.-M., Zhang, Y.-B., Li, X., Ye, G.-L., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00237-5 · Cited by 31
Utility of Cell-Free DNA Detection in Transplant Oncology
Reddy, T. P., Esmail, A., Chang, J. C., Ghobrial, R. M., & Abdelrahim, M. (2022) · Cancers · doi:10.3390/cancers14030743 · Cited by 28
Vrba, L., Futscher, B. W., Oshiro, M. M., Watts, G. S., Menashi, E., Hu, C. K. C., Hammad, H., Pennington, D., Golconda, U., Gavini, H., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01246-2 · Cited by 26
Salani, R., Davidson, B., Fiegl, M., Marth, C., Müller‐Holzner, E., Gastl, G. A., Huang, H.-Y., Hsiao, J.-C., Lin, H.-S., Wang, T., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0853 · Cited by 25
Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma
Primerano, S., Burnelli, R., Carraro, E., Pillon, M., Elia, C., Farruggia, P., Sala, A., Vinti, L., Buffardi, S., Basso, G., et al. (2016) · Journal of Cancer · doi:10.7150/jca.13593 · Cited by 27
Sinville, R., Coyne, J. A., Meagher, R. J., Cheng, Y., Barany, F., Barron, A. E., & Soper, S. A. (2008) · Electrophoresis · doi:10.1002/elps.200800197 · Cited by 25
Screening tests for colorectal cancer: A menu of options remains relevant
Allison, J. E., & Lawson, M. J. (2006) · Current Oncology Reports · doi:10.1007/s11912-006-0079-4 · Cited by 26
Mateos, R. N., Nakagawa, H., Hirono, S., Takano, S., Fukasawa, M., Yanagisawa, A., Yasukawa, S., Maejima, K., Oku‐Sasaki, A., Nakano, K., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2340 · Cited by 26
Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers
Karin‐Kujundžić, V., Šola, I. M., Predavec, N., Potkonjak, A., Somen, E., Mioč, P., Šerman, A., Vranić, S., & Šerman, L. (2019) · Cells · doi:10.3390/cells8111459 · Cited by 28
The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
Shoukry, M. M., Broccard, S. P., Kaplan, J. L., & Gabriel, E. M. (2021) · Cancers · doi:10.3390/cancers13153813 · Cited by 25
Psifidi, A., Dovas, C. Ι., & Banos, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014560 · Cited by 24
Enrichment and Detection of Rare Alleles by Means of Snapback Primers and Rapid-Cycle PCR
Zhou, L., Palais, R. A., Smith, G. D., Anderson, D., Rowe, L. R., & Wittwer, C. T. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.142034 · Cited by 23
Rakislova, N., Montironi, C., Aldecoa, I., Fernández, E., Bombí, J. A., Jimeno, M., Balaguer, F., Pellisé, M., Castells, A., & Cuatrecasas, M. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-016-1114-3 · Cited by 24
Cell-free DNA in non-small cell lung cancer
Gedvilaitė, V., Schveigert, D., & Cicėnas, S. (2017) · Acta medica Lituanica · doi:10.6001/actamedica.v24i2.3495 · Cited by 30
Umelo, I. A., Costanza, B., & Castronovo, V. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9710-0 · Cited by 25
Wang, B., Wu, S., Huang, F., Shen, M., Jiang, H., Yu, Y., Yu, Q., Yang, Y., Zhao, Y., Zhou, Y., et al. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0142 · Cited by 26
Porreca, G. J., Shendure, J., & Church, G. M. (2006) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb0708s76 · Cited by 24
Garofoli, M., Maiorano, B. A., Bruno, G., Giordano, G., Falagario, U. G., Necchi, A., Carrieri, G., Landriscina, M., & Conteduca, V. (2024) · European Urology Oncology · doi:10.1016/j.euo.2024.11.008 · Cited by 28
Induction of apoptosis increases sensitivity to detect cancer mutations in plasma
Marques, J. F., Junqueira-Neto, S., Pinheiro, J., Machado, J. C., & Costa, J. L. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.12.023 · Cited by 23
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
Chang, S. H., Hur, J. Y., Choi, Y., Lee, C. H., & Kim, W. S. (2020) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2020.02.27 · Cited by 24
Jiang, N., Zhou, J., Zhang, W., Li, P., Liu, Y., Shi, H., Zhang, C., Wang, Y., Zhou, C., Peng, C., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13741 · Cited by 23
Clinical applications and perspectives of circulating tumor DNA in gastric cancer
Li, J. M., Zhang, D., Zhu, J., & Dong, L. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03209-4 · Cited by 25
Metadata
- Authors
- Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-10-28
- Volume
- 102
- Issue
- 45
- Pages
- 16368-16373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1283450
- OpenAlex
- W2015438948
- Cited by
- 1,188
- References
- 39
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 44 · 2023: 75 · 2022: 91 · 2021: 76 · 2020: 88 · 2019: 111 · 2018: 97 · 2017: 93 · 2016: 90 · 2015: 66 · 2014: 61 · 2013: 46 · 2012: 44
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA62924, CA43460, CA57345)
- National Cancer Institute (CA 57345, CA43460, R37CA043460, R01CA057345, P50CA062924, R37CA057345, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- circulating tumor DNA, colorectal cancer, APC mutation, liquid biopsy, early cancer detection
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sensitivity and Specificity, Colorectal Neoplasms, Genes, APC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.